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Abstract
Patients with cardiac implantable electronic devices (CIED) and endovascular infec-
tion represent a difficult management group. The explantation of an implantable car-
dioverter-defibrillator (ICD) system deprives the patient of the protection against
life-threatening ventricular tachyarrhythmias. In this study, we describe feasibility
and clinical outcomes of bridging with temporary dual-coil ICD lead and external
ICD following the extraction of a CIED due to endovascular infection and compare
the performance of this approach to other available options.
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1 | INTRODUCTION
The mainstay of treatment in patients with cardiac implantable
electronic device (CIED)-related infection is removal of all hard-
ware.1 The benefit of providing backup defibrillation protection
after explantation of a right ventricular shock lead varies according
to patient’s risk of sudden cardiac death (SCD). In danger are
patients in secondary SCD prevention, and those with earlier
implantable cardioverter-defibrillator (ICD) therapies, relative to pri-
mary prevention patients who have never received appropriate
ICD therapies.2
2 | CASE REPORT
A 64 year-old woman was admitted due to CIED-related infective
endocarditis. Her past medical history was remarkable for non–ST-
segment elevation myocardial infarction in 2001. Subsequent coro-
nary angiogram showed no significant intraluminal lesions. Due to
sick sinus syndrome, she received a dual-chamber permanent
pacemaker in 2001. After cardiac arrest caused by ventricular fibril-
lation in 2002, she was implanted contralaterally with single-cham-
ber ICD for secondary prevention of sudden cardiac death. During
3 months before the index admission, patient had been hospital-
ized twice due to recurrent fever, pneumonia, and massive saddle
pulmonary embolism. At that period, she presented with repetitive
(11 episodes) ventricular tachycardia (VT) which triggered, in total,
33 antitachycardia pacing (ATP) sequences and 16 shocks. Two
episodes of VT lasted for several minutes, a number of ICD thera-
pies were ineffective, and VT was terminated with 5th shock and
9th shock, respectively. Lead-dependent infective endocarditis was
diagnosed based on fever, vegetations, and septic pulmonary
embolism. Blood cultures were negative. After admission to tertiary
referral center for transvenous lead extraction (TLE), a single-step
procedure of complete transvenous extraction of all hardware was
performed with the use of mechanical systems (Byrd Polypropylene
Dilator Sheath Set, Cook MedicalTM). The ICD lead was identified
as the most challenging to extract and was hence extracted first;
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the whole DDD pacemaker was then extracted from the left side
of chest. As a bridge to permanent ICD reimplantation, a tempo-
rary system was implanted, consisting of an active-fixation dual-coil
DF4 ICD lead (St. Jude Medical DurataTM 7120Q-65) inserted via
percutaneous puncture of the left subclavian vein, anchored to the
skin, and attached to an epicutaneous single-chamber defibrillator
(St. Jude Medical EllipseTM VR) (Figure 1A-B). “Active-can” ICD was
turned off, and the shock polarity was programmed from the right
ventricular coil to the superior vena cava coil. Two weeks later,
patient developed two episodes of VT, one of which was stopped
by a first burst of ATP (Figure 2A), and the other did not respond
to ATP sequence and was terminated with a 35 J shock (Fig-
ure 2B-C). The ventricular arrhythmia was triggered by sinus brady-
cardia (Figure 2D); hence, later overdrive VVI pacing at 70 beats
per minute fully suppressed the ventricular tachyarrhythmia for the
remaining period of the endocarditis treatment (Figure 2E). Her
antiarrhythmic treatment consisted of sotalol increased from 80 mg
twice daily to three times daily. Chronic treatment with amio-
darone was deferred due to the past medical history of
amiodarone-induced thyrotoxicosis. Antibiotic treatment consisted
of vancomycin 1 g twice daily and ceftriaxone 2 g twice daily.
Finally, 6 weeks after the TLE procedure, a new dual-chamber ICD
with single-coil shock lead was implanted in the left pectoral
region, and temporary ICD system was removed with simple trac-
tion. Evaluation at a 3 month follow-up showed that the patient
was in good condition.
3 | DISCUSSION
Bridging patients with prior ICD therapies who require continuous
ICD backup in the period between device explantation and reimplan-
tation is particularly challenging.2 The options available to physicians
include immobilization in an intensive care unit or telemetry ward,
with continuous ECG monitoring where instant access to external
defibrillation is provided; a wearable cardioverter-defibrillator (WCD)
3; and a subcutaneous ICD (S-ICD) as a permanent reimplantation
device.4
A promising approach for patients in whom ICD implantation
must be deferred, but in whom there is an urgent need to manage
malignant tachyarrhythmias, is bridging with a temporary external
ICD. Cooper et al reported a successful use of external ICD, pro-
grammed to burst ATP therapies only and connected to an active-
fixation pacemaker lead, in a patient who had both an ICD infection
and a history of recurrent VT (responsive to single ATP therapy).5
Furthermore, in a similar setting, Dell’Era et al showed efficacious
delivery of ATP and shock from a system consisting of a temporary
dual-coil active-fixation DF4 lead, connected to an external ICD with
passive-can shock configuration.6 Our case demonstrates an addi-
tional method of controlling heart rhythm with VVI overdrive pacing,
which has not been described in the aforementioned reports.
The noteworthy benefit of the temporary external ICD system
over WCD is that it automatically starts treatment, whereas the lat-
ter is interactive and significantly depends on patient compliance.
Moreover, an external ICD shares the same capacities as a traditional
ICD, enabling bradycardia pacing, overdrive pacing, and ATP thera-
pies. These are unavailable in the treatment choices involving “exter-
nal” defibrillation, such as continuous ECG monitoring in an intensive
care unit, WCD, and S-ICD.
A limitation of the presented technique is a temporary ICD lead
in the vascular system, which may impede complete infection elimi-
nation and contribute to increased risk of infection recurrence.
Promising short-term outcomes with no early infection recurrences
were reported by Maciazg et al in a retrospective analysis of 34 pace-
maker-dependent patients. The patients were bridged with external-
ized active-fixation pacing lead for 4-26 days following TLE due to
infection.7 Amraoui et al in a retrospective analysis of 80 consecu-
tive pacemaker-dependent patients bridged with externalized pacing
lead for 4-14 days reported excellent short- and long-term effects
with no early lead dislodgement and no infection recurrence at
1 year follow-up.8 Of note, Perrin et al presented follow-up out-
comes in the group of 52 pacemaker-dependent patients who were
(A)
(B)
F IGURE 1 A, ICD lead implanted via a percutaneous puncture of
the left subclavian vein, sutured to the skin, and connected to ICD
unit; B, Chest x-ray after lead extraction and temporary dual-coil
ICD lead implantation
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bridged with screwed-in temporary lead for 11.1  9.7 days and ret-
rospectively followed up for a mean period of 25.2 months: Eight
patients (15.4%) developed vegetations on their temporary lead; one
temporary lead dislodged with sudden loss of capture; and one
patient developed a CIED reinfection after 21 months of follow-up.9
Undoubtedly, a prospective study would be required to fully assess
the long-term safety of temporary lead bridging. Importantly, in the
above-mentioned studies by Maciazg et al and Perrin et al, up to
20% of patients had an infected ICD system,7,9 whereas in the study
by Amraoui et al, ICD patients were excluded from analysis.8
The technique described above provides an important option for
prolonged ICD backup. The presented case shows that a temporary
external ICD is an efficacious bridge to permanent device
reimplantation.
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